STX — Shield Therapeutics Share News
0.000.00%
Last trade - 00:00- £24.48m
- £36.35m
- £13.09m
REG - Shield Therapeutics - Q1 2025 Trading Update
AnnouncementREG - Shield Therapeutics - ACCRUFeR® launched in Canada
AnnouncementREG - Shield Therapeutics - PDMR Transaction Notification
AnnouncementREG - Shield Therapeutics - Grant of Share Options
AnnouncementREG - Shield Therapeutics - Unaudited full year trading update
AnnouncementREG - Shield Therapeutics - Anders Lundstrom appointed CEO
AnnouncementREG - AIM - AIM Notice - 30/12/2024
AnnouncementREG - Shield Therapeutics - Result of General Meeting & Total Voting Rights
AnnouncementREG - Shield Therapeutics - Results of RetailBook Offer
AnnouncementREG - Shield Therapeutics - RetailBook Offer
AnnouncementREG - Shield Therapeutics - Subscription by AOP Health to raise US$10 million
AnnouncementREG - Shield Therapeutics - Business Update
AnnouncementREG - Shield Therapeutics - Q3 Trading Update
AnnouncementREG - Shield Therapeutics - Results from Phase 3 paediatric study
AnnouncementREG - Shield Therapeutics - Interim results
AnnouncementREG - Shield Therapeutics - ACCRUFeR® Approved by Health Canada
AnnouncementREG - Shield Therapeutics - Notice of interim results
AnnouncementREG - Shield Therapeutics - Unaudited Q2 2024 Trading Update
AnnouncementREG - Shield Therapeutics - Directorate Change
Announcement